PVLA · Company research

Palvella Therapeutics, Inc. (PVLA): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 2026128$2,007,430,102.771953173102.77————45.2480582163867914—

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.